CPhI Middle East & AfricaDate: 3rd Monday, 2018 Time: TBA Venue: ADNEC Centre, Abu Dhabi, United Arab Emirates (UAE)
CPhI Middle East & Africa will be the region’s most comprehensive pharma gathering. Together, with its co-located events ICSE, P-MEC, InnoPack and FDF, will host over 4,000 key visiting pharma suppliers and buyers. With a wide range of exhibitors from all across the entire pharma supply chain, don’t miss out on your chance to participate at this unrivalled meeting point in Abu Dhabi.
Experience the entire pharma supply chain under one roof:
- CPhI: for pharmaceutical ingredients
- FDF: for every aspect of the finished dosage supply chain
- ICSE: for outsourcing solution providers, contract manufacturing and services
- InnoPack: for pharmaceutical packaging and drug delivery systems
- P-MEC: for pharmaceutical machinery, technology and equipment
When: 03-05 September 2018
Where: ADNEC Centre, Abu Dhabi, United Arab Emirates (UAE)
Registration: Please click here
Who will attend?
Pharma professionals representing companies from the across the full spectrum of the supply chain, both regionally and internationally. Over 60% of attendees hold a key decision making role with their company, allowing your company to grow potential new business with the right people.
CPhI report predicts new finished product manufacturing hub in the Middle East
A new report by CPhI forecasts sizable changes ahead for the pharma markets in the Middle East and Africa over the next few years. It highlights recent regulatory changes, coupled with increased geopolitical stability and rising generics consumption as key drivers in transforming the prospects of pharma manufacturers in the region.
The CPhI Middle East and Africa report – released ahead of the inaugural edition of CPhI MEA – has identified significant opportunities for a region that is often overlooked by much of international pharma. The event will attract leaders and key decision makers of the pharma industry from the Middle East and Africa, bringing the expertise and reach of the CPhI brand to the heart of this new pharma hub. Running alongside the exhibition, there will be content sessions on the latest trends, keynote addresses, and numerous networking opportunities.
“Our report shows that there two types of market in the region, and both are likely to grow extremely quickly in the near term. The high-income economies offer excellent opportunities for innovative and branded medicines, whilst the free trade agreement between the GCC (Gulf Cooperation Council) nations will undoubtedly increase generics consumption. Additionally, high growth economies in Africa (notably Nigeria, Ghana and South Africa) also look a good bet for rapid generics growth over the next 5-years [with compound annual growth rates of around 10% each].” Cara Turner, Brand Manager – CPhI Middle East & Africa at UBM.
Manufacturers in India look very well placed to capitalise thanks to the recent free trade deal with the GCC – a multinational partnership consisting of Bahrain, Oman, Saudi Arabia, Kuwait, the UAE and Qatar – which has significantly reduced trade barriers. Additionally, the GCC has also set in place a drug price harmonisation strategy in order to standardise drug prices within the region.
However, due the purchasing power and a cultural preference for domestic products. In the short term, it is more likely that Indian and other API manufacturers will be the largest beneficiary, with local companies providing the final product manufacturing.
CPhI Middle East & Africa 2018 comes with the backing of regional government and pharma associations, and is expected to attract over 200 local, regional and international exhibitors from 30 countries.
One final trend, is that in light of the new opportunities, foreign direct investment by large pharma and generics companies is increasing with the goal of acquiring local manufacturing facilities.
Cara added “international companies looking at the opportunities that abound in this region must appreciate cultural business norms. Our feedback from the market says that no matter how large a company or positive its international repute, there is a great deal of importance placed in building personal relationships with potential business partners. It’s also one of the reasons we have introduced Live Pharma Connect, a Match & Meet service, as well as a new Hosted Buyer Programme at the event to help build these new networks”
CPhI MEA will take place at the ADNEC Centre, Abu Dhabi, United Arab Emirates (UAE), attracting leaders and key decision makers to the heart of this new pharma hub. The event will co-locate ICSE, P-MEC, Innopack and FDF, providing the opportunity to meet with regional drug manufacturers, suppliers of pharma ingredients, distributors, finished dose manufacturers, and companies involved in pharma machinery, packaging and contract services.
If you would like to register for this event, please click here